Tracheal cytotoxin (TCT) is a disaccharidetetrapeptide released by Bordetella pertussis, the causative agent of pertussis (whooping cough). We have previously determined the structure of TCT to be GIcNAc-1,6-anhydroMurNAc-L-Ala-y-D-Glu-meso-A2pm-D-Ala, where MurNAc = N-acetylmuramic acid and A2pm = diaminopimelic acid. Purified TCT reproduces the respiratory cytopathology observed during pertussis, including ciliostasis and extrusion of ciliated cells. We have tested structural analogs of TCT for their ability to reproduce native TCT toxicity in explanted hamster tracheal tissue and hamster trachea epithelial (HTE) cell cultures. Other investigators have evaluated many of these analogs, which are muramyl or desmuramyl peptides, for muramyl peptide activities such as immunopotentiation, induction of slow-wave sleep, and pyrogenicity. Four desmuramyl peptides were produced in our laboratory from B. pertussis peptidoglycan or by chemical synthesis, including unusual peptides containing a-aminopimelic acid in place of A2pm. Based on the relative ability of compounds to inhibit DNA synthesis in HTE cells, truncated analogs lacking A2pm entirely or lacking only the side-chain amine or carboxyl group of A2pm were less active than TCT by a factor of at least 1000. All active analogs included a native or near-native peptide moiety, independent of the presence, absence, or substitution of the sugar moiety. We conclude that the structural requirements for TCT toxicity differ considerably from those for most other muramyl peptide activities, in that the disaccharide moiety is irrelevant for toxicity and both the free amino and carboxyl groups of the A2pm side chain are required for activity.Tracheal cytotoxin (TCT) is a low molecular weight glycopeptide released during logarithmic-phase growth of Bordetella pertussis. It is the only B. pertussis product that reproduces the respiratory cytopathology observed during pertussis (whooping cough) (1). This pathology includes ciliostasis and specific extrusion of ciliated cells from the respiratory epithelium. In the absence of ciliary activity, coughing becomes the only way to clear the airways of accumulating mucus, bacteria, and inflammatory debris. Thus, TCT-mediated destruction of ciliated cells may trigger the violent coughing episodes symptomatic of pertussis. In addition, the absence of a ciliary clearance mechanism predisposes patients to secondary pulmonary infections, the primary cause of pertussis mortality (2).We have previously reported the purification of TCT by reversed-phase HPLC (RP-HPLC) and determined its structure by fast atom bombardment (FAB)-MS to be GlcNAc-1,6-anhydro-MurNAc-L-Ala-y-D-Glu-meso-A2pm-D-Ala (Fig. 1) (3), where MurNAc is N-acetylmuramic acid and A2pm is diaminopimelic acid. TCT belongs to a family of compounds known as muramyl peptides, which have many biological activities including adjuvanticity, somnogenicity, and pyrogenicity (4-6). Naturally occurring muramyl peptides are of bacterial origin; they are fragments of peptidoglycan, t...